InfuSystem Holdings Action

InfuSystem Holdings Dettes/EBITDA

Ratio de la Dette Totale sur EBITDA de InfuSystem Holdings (INFU) au 22 août 2026 est 1,49. L'année précédente, Ratio de la Dette Totale sur EBITDA était 2,60 — une variation de -42,50 % (plus faible).

Dettes/EBITDA

1,49

YoY

-42,50%

Dernière mise à jour:

Ratio de la Dette Totale sur EBITDA de InfuSystem Holdings est 2026 1,49 . Ratio de la Dette Totale sur EBITDA de InfuSystem Holdings était 2025 2,60 . Elle diminue ainsi de -42,50% plus faible par rapport à l'année précédente.

L'histoire de InfuSystem Holdings Dettes/EBITDA

  • 3 ans

  • 10 ans

  • 25 ans

  • Max

Dettes/EBITDA
Date
Dettes/EBITDA
1 janv. 2017
13,55 USD
1 janv. 2018
6,18 USD
1 janv. 2019
4,55 USD
1 janv. 2020
2,79 USD
1 janv. 2021
4,15 USD
1 janv. 2022
6,32 USD
1 janv. 2023
4,71 USD
1 janv. 2024
2,60 USD
L'histoire de InfuSystem Holdings Dettes/EBITDA
ANNÉEDettes/EBITDAYoY
2,60-44,82%
4,71-25,44%
6,32+52,37%
4,15+48,67%
2,79-38,76%
4,55-26,33%
6,18-54,38%
13,55+96,46%
6,90+144,65%
2,82+34,37%
2,10
Access this data via the Eulerpool API

InfuSystem Holdings Analyse d'actions

Que fait InfuSystem Holdings ? InfuSystem Holdings Inc. is a leading provider of ambulatory infusion therapy management solutions for patients and healthcare facilities in the United States. Founded in 2005 and based in Madison Heights, Michigan, the company has experienced significant growth in recent years and is expanding its services on a national level. History: InfuSystem was founded to fill a gap in the healthcare industry. The company aimed to specialize in the management of infusion therapies and provide reliable and convenient care for patients suffering from chronic illnesses. In recent years, InfuSystem has expanded the number of services and products offered and has expanded its customer base nationally. Business model: InfuSystem's business model is based on providing ambulatory infusion therapy management solutions for patients with chronic illnesses. The company offers various categories of services, including rental and sale of pumps and accessories, clinical support, insurance coordination, patient education and monitoring. The main goal is to ensure high-quality and convenient patient care, as well as maintain positive interaction with treating physicians and numerous caregivers. In addition, the company also provides its customers with excellent support and training for medical professionals. Divisions: InfuSystem is divided into three business segments that cover different categories of patient needs: 1. Infusion pump rental and sales: The company offers a wide range of infusion pumps and other accessories for purchase or rental, depending on the needs of patients and healthcare facilities. 2. Medication handling: InfuSystem provides customers with a safe and reliable solution for the handling of infusion medications, including what to do with unused inventory and ensuring proper waste disposal. 3. Reliable clinical support: In order to guarantee customers with the best possible care, InfuSystem offers a wide range of clinical services, including therapy monitoring, pump setting adjustments, training for medical professionals, and much more. Products: InfuSystem offers a wide range of pumps and accessories for infusion therapy. The products offered include chemotherapy pumps, analgesia pumps, antibiotic pumps, nutrition pumps, oncology pumps, and much more. The company also provides accessories such as infusion sets, smart pumps, and backflow filters. Conclusion: InfuSystem operates as a trusted partner for patients and healthcare facilities in need of high-quality and convenient infusion therapy. With its extensive range of pumps and accessories for infusion therapy, as well as clinical support services, InfuSystem provides personalized and reliable care for patients whose lives are affected by chronic diseases. InfuSystem Holdings est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action InfuSystem Holdings

Ratio de la Dette Totale sur EBITDA de InfuSystem Holdings s'élève à 1,49 en 2026.

Ratio de la Dette Totale sur EBITDA de InfuSystem Holdings a changé de 2,60 à 1,49, ce qui représente une variation de -42,50 %. La valeur est plus faible qu'l'année précédente.

Sur Eulerpool, vous trouverez l'évolution historique complète de InfuSystem Holdings de Ratio de la Dette Totale sur EBITDA depuis 2006 – avec des valeurs annuelles, des graphiques et une analyse détaillée.

Dette/EBITDA mesure la dette totale par rapport au résultat avant intérêts, impôts, amortissements et dépréciations. Elle indique le nombre d'années nécessaires pour rembourser toute la dette à partir de l'EBITDA.

Un 'bon' varie selon le secteur et le stade de l'entreprise. Sur Eulerpool, vous pouvez comparer InfuSystem Holdings de Ratio de la Dette Totale sur EBITDA avec les pairs du secteur et la moyenne du secteur pour évaluer son attrait.

Access this data via the Eulerpool API

Endettement — InfuSystem Holdings

Toutes les Métriques Clés — InfuSystem Holdings

Croissance